NCT/Study#

CP-NEXI-002-01

A Phase 1 / 2 Study to Evaluate the Safety and Tolerability of Adoptively Transferred Autologous T cells in Patients with Relapsed Refractory Multiple Myeloma

A Phase 1 / 2 Study to Evaluate the Safety and Tolerability of Adoptively Transferred Autologous T cells in Patients
with Relapsed Refractory Multiple Myeloma

DISEASE GROUP:
Multiple Myeloma
current phase:
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: